Acacia Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Acacia Pharma's estimated annual revenue is currently $5M per year.
- Acacia Pharma's estimated revenue per employee is $201,000
Employee Data
- Acacia Pharma has 25 Employees.
- Acacia Pharma grew their employee count by -37% last year.
Acacia Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | EVP, Chief Financial Officer | Reveal Email/Phone |
Acacia Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.6M | 23 | 0% | N/A | N/A |
#2 | $23.5M | 117 | -28% | N/A | N/A |
#3 | $575.7M | 2864 | 2% | N/A | N/A |
#4 | $1.8M | 18 | -10% | $1.5M | N/A |
#5 | $5.8M | 29 | -6% | N/A | N/A |
#6 | $10.7M | 53 | 15% | N/A | N/A |
#7 | $271.4M | 1350 | 4% | N/A | N/A |
#8 | $9.2M | 46 | 10% | N/A | N/A |
#9 | $27760M | 44397 | 4% | N/A | N/A |
#10 | $1.2M | 6 | -54% | N/A | N/A |
What Is Acacia Pharma?
Acacia Pharma, Inc. is a commercially driven hospital pharmaceutical group focused on the development and commercialization of new nausea and vomiting treatments for surgical and cancer patients. The Company has identified important and commercially attractive unmet needs in nausea and vomiting and has discovered two product candidates based on the same active ingredient, amisulpride, to meet those needs. Join our team: http://www.acaciapharma.com/join-our-team/current-openings
keywords:N/A
N/A
Total Funding
25
Number of Employees
$5M
Revenue (est)
-37%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Acacia Pharma News
For 15 years, Acacia Pharma Group operated quietly below the radar, developing specialty drugs for patients undergoing surgery and invasive...
ACACIA PHARMA GROUP PLC. PROPOSED TRANSACTION WITH EAGLE PHARMACEUTICALS, INC. THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION AND INSIDE...
Acacia Pharma is a hospital pharmaceutical company focused on the development and commercialization of new products aimed at improving the...
Acacia Pharma Group plc 2021 Mid-Year Results Presentation September 30, 2021 Transforming Medicine Advancing Care Important Notice The information contained in this presentation (this "presentation") has been prepared by Acacia Pharma Group plc ("the Company") as at the date of this present ...
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Acacia Pharma Group plc Barhemsys® and Byfavo® launches continue to show strong progress gaining formulary access in 107 additional accounts over the past 3 monthsFor Bar ...
Other Companies in Indianapolis
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4M | 25 | 0% | N/A |
#2 | $1.7M | 25 | -11% | N/A |
#3 | $5.7M | 25 | -4% | N/A |
#4 | $2.5M | 25 | 4% | N/A |
#5 | N/A | 25 | 79% | N/A |